Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$5.01 - $8.35 $661,841 - $1.1 Million
-132,104 Reduced 14.67%
768,607 $5.6 Million
Q3 2022

Nov 14, 2022

SELL
$4.92 - $9.1 $488,501 - $903,529
-99,289 Reduced 9.93%
900,711 $7.29 Million
Q2 2022

Aug 12, 2022

BUY
$4.2 - $24.0 $1.47 Million - $8.4 Million
350,000 Added 53.85%
1,000,000 $4.9 Million
Q1 2022

May 16, 2022

SELL
$9.96 - $23.65 $996,000 - $2.37 Million
-100,000 Reduced 13.33%
650,000 $15.4 Million
Q4 2021

Feb 14, 2022

BUY
$14.0 - $28.44 $10.5 Million - $21.3 Million
750,000 New
750,000 $13.3 Million

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $156M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.